Totus Medicines

About:

Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.

Website: https://www.totusmedicines.com

Twitter/X: totustx

Top Investors: Regents of The University of Minnesota, Northpond Ventures, Social Impact Capital, DCVC Bio, Camford Capital

Description:

Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome. Leveraging its groundbreaking platform, Totus Medicines can simultaneously screen billions of drug candidates against thousands of targets, identifying superior molecules. This includes candidates for traditionally challenging, undruggable targets.

Total Funding Amount:

$106M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)totusmedicines.com

Founders:

Jimmy Blair, Neil Dhawan

Number of Employees:

11-50

Last Funding Date:

2023-12-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai